Discover 3,043 paid clinical trials in Thousand Oaks, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,043
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Los Angeles CA, Aurora CO, Columbus OH, Orlando FL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06233942
Phase 1, Recruiting
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
for
Gastric Cancer, Gastric Adenocarcinoma,
Location: Duarte CA, Fairfax VA
Sponsor: BigHat Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07529808
Phase 1, Phase 2, Recruiting
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
for
Colorectal Cancer Metastatic
Location: Los Angeles CA, Newport Beach CA, Atlanta GA
Location: Los Angeles CA, Orange CA, Dallas TX, Houston TX,
Sponsor: KaliVir Immunotherapeutics
Sex: All
Age: 18+
Code: NCT06444815
Phase 1, Recruiting
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
for
Squamous Non-small-cell Lung Cancer,
Location: Los Angeles CA, Fullerton CA, Scottsdale AZ, Chicago IL,
Sponsor: Alentis Therapeutics AG
Sex: All
Age: 18+
Code: NCT06747585
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
for
Pregnant Individuals, Aneuploidy, Down Syndrome (Trisomy 21),
Location: West Covina CA, Riverside CA, Phoenix AZ, Houston TX,
Sponsor: BillionToOne Inc.
Sex: Female
Age: 0+
Code: NCT07643896
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
for
Cervical Cancer,
Location: Los Angeles CA, Newport Beach CA, Clovis CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT04895709
Phase 1, Phase 2, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Location: Long Beach CA, Santa Barbara CA, Fullerton CA,
Sponsor: Amgen
Sex: All
Age: 50+
Code: NCT07614776
Phase 3, Recruiting
Effect of a Fasting Mimicking Diet on Patients With Multiple Sclerosis (FMDMS)
for
Multiple Sclerosis
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18 - 55
Code: NCT06515782
Recruiting
Dextromethorphan for Treatment of Postoperative Pain
for
Post-operative Pain
Location: Los Angeles CA
Sponsor: Nathanael Heckmann
Sex: All
Age: 18+
Code: NCT05278494
Recruiting
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
for
Stroke, TIA, Ischemic Stroke, Ischemic
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 30+
Code: NCT05518305
Recruiting
Polyphenols and Cognitive Decline
for
Cognitive Decline, Cognitive Dysfunction
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 50+
Code: NCT06507254
Recruiting
Keck Medicine of University of Southern California Thrive Study
for
Burnout
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 0+
Code: NCT05780892
Recruiting
Evaluation of Neurocognitive Changes in Parkinson's Disease After Low Frequency Burst Stimulation
for
Parkinson Disease
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT05307055
Recruiting
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
for
Astrocytoma, IDH-Mutant, Grade 2,
Location: Duarte CA, Orange CA, Irvine CA, La Jolla CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06860594
Phase 1, Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Torrance CA, Stockton CA, Salem OR, Tacoma WA,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07091019
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)